Baseline characteristics and hospitalizations in patients with schizophrenia receiving olanzapine long-acting injection: an interim analysis from a non-interventional, prospective observational safety study

被引:0
作者
Meghan E. Jones
Jeffrey S. Andrews
Douglas E. Faries
John Landry
Jenny Xu
Holland C. Detke
Rashna Chhabra-Khanna
David P. McDonnell
机构
[1] Eli Lilly and Company,
[2] Eli Lilly Canada,undefined
[3] Inc.,undefined
[4] MacroStat (China) Clinical Research Co.,undefined
[5] Ltd.,undefined
[6] Lilly UK,undefined
[7] Eli Lilly and Company,undefined
来源
BMC Psychiatry | / 15卷
关键词
Olanzapine; Long-acting injection; Schizophrenia; Antipsychotics;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 123 条
  • [1] Sawa A(2002)Schizophrenia: diverse approaches to a complex disease Science 296 692-695
  • [2] Snyder SH(1998)Compliance with medication regimens for mental and physical disorders Psychiatr Serv 49 196-201
  • [3] Cramer JA(2003)Adherence to antipsychotic and nonpsychiatric medications in middle-aged and older patients with psychotic disorders Psychosom Med 65 156-162
  • [4] Rosenheck R(2006)Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia J Clin Psychiatry 67 3-8
  • [5] Dolder CR(2003)Clinical interventions for treatment non-adherence in psychosis: meta-analysis Br J Psychiatry 183 197-206
  • [6] Lacro JP(2000)Compliance with antipsychotic treatment Acta Psychiatr Scand Suppl 407 83-86
  • [7] Jeste DV(2002)Antipsychotic medication adherence: is there a difference between typical and atypical agents? Am J Psychiatry 159 103-108
  • [8] Leucht S(2003)Strategies for improving compliance in treatment of schizophrenia by using a long-acting formulation of an antipsychotic: clinical studies J Clin Psychiatry 64 34-40
  • [9] Heres S(2002)Predictors of noncompliance in patients with schizophrenia J Clin Psychiatry 63 1121-1128
  • [10] Nose M(1997)Factors influencing relapse in the long-term course of schizophrenia Schizophr Res 28 199-206